Project Grant K01HL171461
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$132K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA
Similar Awards
This federal Project Grant award of $748,829 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) supports research to explore the connection between a compromised "metabolic resuscitation system" and the pathogenesis of heart failure. The overarching objective is to determine how this novel system relates to the progression of heart failure and evaluate its potential as a therapeutic target and biomarker for...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research (CFDA 93.837) program, provides $732,779 to the University of Arizona to study the role of the serine-threonine kinase SGK1 in cardiometabolic heart failure with preserved ejection fraction (CMET HFPEF). The research aims to determine how cardiac-specific SGK1 regulates heart function, metabolism, and...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $171,450 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a 2-year research project from September 1, 2024 to August 31, 2026. The research aims to investigate the biological mechanisms linking excess body fat (adiposity) and elevated blood lipid levels, which are major risk factors for cardiovascular...
This federal Project Grant award for $115,949 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), supports research to understand the relationship between obesity, inflammation in visceral adipose tissue, and metabolic dysfunction. The University of California, San Francisco, is the primary awardee, with the goal of delineating adipose tissue topography using spatial sequencing, microscopy, and flow cytometry to identify...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $154,568 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant, entitled "Using Defective Lipoylation as a Window into Cardiac Fuel Consumption and Failure," aims to characterize the underlying causes of cardiometabolic distress using novel mouse models of cardiac lipoic acid deficiency. The central hypothesis...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), provides $604,818 to the University of Mississippi Medical Center to investigate the role of non-alcoholic fatty liver disease (NAFLD) in the development of cardiovascular disease. The key objectives are to determine whether increasing plasma levels of the ketone body β-hydroxybutyrate (BHB) or the hepatokines nerve growth factor...
This $148,568 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the physiological regulation of energy intake during meals following weight loss. The research will leverage data from two ongoing NIDDK-funded studies - the ARROW study (R01DK114272) and the TIME2EAT study (R01DK132372) - to analyze energy balance, gut hormone...
This $121,773 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the role of the cytosolic kinase SGK1 in driving pathological cardiac hypertrophy, and whether modulating its degradation via non-canonical ER-associated degradation (ERAD) can mitigate this condition. The research aims to 1) determine the effects of depleting endogenous SGK1 on cardiac myocyte...
This $741,512 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support research on the role of the transcription factor NRF2 in regulating cardiac sympathetic tone and arrhythmogenesis in chronic heart failure. The University of Nebraska Medical Center, through its Board of Regents, will conduct this 4-year research project. The study aims to: 1) evaluate the time-course changes in neural...
This $153,512 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to explore the role of the MTCH2 gene in regulating cardiac function and body composition. The project aims to investigate how reduction of the MTCH2 protein impacts mitochondrial dysfunction, sarcomere function, and the development of cardiomyopathy, especially when combined with a high-fat diet. Specific objectives...